Dr Abhishek Kumar, MD in Las Vegas, NV - Medicare Pulmonary Disease

Dr Abhishek Kumar, MD is a medicare enrolled "Internal Medicine - Pulmonary Disease" physician in Las Vegas, Nevada. He graduated from medical school in 2004 and has 20 years of diverse experience with area of expertise as Pulmonary Disease. He is a member of the group practice Healthtexas Provider Network and his current practice location is 1707 W Charleston Blvd Ste 270, Las Vegas, Nevada. You can reach out to his office (for appointments etc.) via phone at (702) 485-4400.

Dr Abhishek Kumar is licensed to practice in Nevada (license number 21077) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1639443823.

Contact Information

	Dr Abhishek Kumar, MD
	1707 W Charleston Blvd Ste 270, Las Vegas, NV 89102-2351
	(702) 485-4400
	(702) 485-4405

Physician's Profile

Full Name	Dr Abhishek Kumar
Gender	Male
Speciality	Pulmonary Disease
Experience	20 Years
Location	1707 W Charleston Blvd Ste 270, Las Vegas, Nevada
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Abhishek Kumar graduated from medical school in 2004

NPI Data:

NPI Number: 1639443823
Provider Enumeration Date: 03/06/2012
Last Update Date: 12/13/2022

Medicare PECOS Information:

PECOS PAC ID: 3870806037
Enrollment ID: I20230223000662

Medical Identifiers

Medical identifiers for Dr Abhishek Kumar such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1639443823	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RP1001X	Internal Medicine - Pulmonary Disease	E-13239 (Arkansas)	Secondary
207RP1001X	Internal Medicine - Pulmonary Disease	MD-42458 (Iowa)	Secondary
207RP1001X	Internal Medicine - Pulmonary Disease	21077 (Nevada)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Baylor University Medical Center	Dallas, TX	Hospital
Baylor Scott & White Heart & Vascular Hospital - Dallas	Dallas, TX	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Healthtexas Provider Network	1355254210	1810

News Archive

Aclidinium and formoterol combination demonstrates significant lung function improvement in the second pivotal efficacy trial

Almirall, S.A. (ALM:MC) and Forest Laboratories, Inc. (NYSE:FRX) today announced positive topline results from AUGMENT/COPD, the second six-month pivotal phase III clinical trial evaluating the efficacy and safety of investigational fixed dose combinations of aclidinium bromide (LAMA) and formoterol fumarate (LABA) for the treatment of Chronic Obstructive Pulmonary Disease (COPD), delivered in the Pressair™ inhaler (Genuair® outside the USA).

FDA issues Proposal to Withdraw Marketing Approval for orthostatic hypotension drug midodrine hydrochloride

The U.S. Food and Drug Administration today proposed to withdraw approval of the drug midodrine hydrochloride, used to treat the low blood pressure condition orthostatic hypotension, because required post-approval studies that verify the clinical benefit of the drug have not been done.

Human bivalent SARS-CoV-2 neutralizing antibodies more potent

A recent study published on the preprint server bioRxiv in October 2020 reports more effective viral neutralization by bivalent anti-spike antibodies. This could promote the development of better therapeutics and vaccines.

Researchers identify molecular mechanisms that can prevent blindness, promote recovery from stroke

Research led by Nicolas Bazan, MD, PhD, Boyd Professor, Ernest C. and Yvette C. Villere Chair of Retinal Degeneration Research, and Director of the Neuroscience Center of Excellence at LSU Health New Orleans, has discovered gene interactions that determine whether cells live or die in such conditions as age-related macular degeneration and ischemic stroke.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Abhishek Kumar allows following entities to bill medicare on his behalf.

Entity Name	Healthtexas Provider Network
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1760488936 PECOS PAC ID: 1355254210 Enrollment ID: O20040727001187

News Archive

Aclidinium and formoterol combination demonstrates significant lung function improvement in the second pivotal efficacy trial

FDA issues Proposal to Withdraw Marketing Approval for orthostatic hypotension drug midodrine hydrochloride

Human bivalent SARS-CoV-2 neutralizing antibodies more potent

Researchers identify molecular mechanisms that can prevent blindness, promote recovery from stroke

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Abhishek Kumar is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Abhishek Kumar, MD 3016 W Charleston Blvd Ste 100, Las Vegas, NV 89102-1973 Ph: (702) 218-0915	Dr Abhishek Kumar, MD 1707 W Charleston Blvd Ste 270, Las Vegas, NV 89102-2351 Ph: (702) 485-4400

News Archive

Aclidinium and formoterol combination demonstrates significant lung function improvement in the second pivotal efficacy trial

FDA issues Proposal to Withdraw Marketing Approval for orthostatic hypotension drug midodrine hydrochloride

Human bivalent SARS-CoV-2 neutralizing antibodies more potent

Researchers identify molecular mechanisms that can prevent blindness, promote recovery from stroke

Internal Medicine Doctors in Las Vegas, NV

Dr. Arshi A. Quadeer, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2545 S Bruce St Ste 200, Las Vegas, NV 89169 Phone: 702-732-2438 Fax: 702-737-5043
Cherie Lin, D.O. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 3006 S Maryland Pkwy, Suite 400, Las Vegas, NV 89109 Phone: 702-369-5582 Fax: 702-369-1533
Michael M Lee, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-921-6823 Fax: 702-549-5240
Henry Palangdao Igid, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 653 N Town Center Dr Ste 402, Las Vegas, NV 89144 Phone: 702-243-7200 Fax: 702-243-7235
Ian Adrian Fanoga Frani, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-383-2000 Fax: 702-383-3875
Sein Tun, DO Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 620 Shadow Ln, Las Vegas, NV 89106 Phone: 702-388-4000
Berge Jack Dadourian, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 400 S Rampart Blvd, Suite 240, Las Vegas, NV 89145 Phone: 702-906-1100 Fax: 702-906-1110

Dr Abhishek Kumar, MD - Medicare Pulmonary Disease in Las Vegas, NV

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Aclidinium and formoterol combination demonstrates significant lung function improvement in the second pivotal efficacy trial

FDA issues Proposal to Withdraw Marketing Approval for orthostatic hypotension drug midodrine hydrochloride

Human bivalent SARS-CoV-2 neutralizing antibodies more potent

Researchers identify molecular mechanisms that can prevent blindness, promote recovery from stroke

Medicare Reassignments

Aclidinium and formoterol combination demonstrates significant lung function improvement in the second pivotal efficacy trial

FDA issues Proposal to Withdraw Marketing Approval for orthostatic hypotension drug midodrine hydrochloride

Human bivalent SARS-CoV-2 neutralizing antibodies more potent

Researchers identify molecular mechanisms that can prevent blindness, promote recovery from stroke

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Aclidinium and formoterol combination demonstrates significant lung function improvement in the second pivotal efficacy trial

FDA issues Proposal to Withdraw Marketing Approval for orthostatic hypotension drug midodrine hydrochloride

Human bivalent SARS-CoV-2 neutralizing antibodies more potent

Researchers identify molecular mechanisms that can prevent blindness, promote recovery from stroke

Internal Medicine Doctors in Las Vegas, NV